A group of medical entities released its own vaccine recommendations in the face of President Trump’s executive order urging children to have fewer vaccines.
“The newest evidence continues to demonstrate that immunization provides meaningful protection against hospitalization, severe illness and death. The degree of protection varies by virus, vaccine or immunization product, population, season and circulating strains,” the Vaccine Integrity Project and the American Medical Association (AMA) said in its findings.
“No new safety concerns were identified in comparative studies evaluating currently recommended immunizations. The findings are consistent with the well-established safety profiles of influenza and COVID-19 vaccines and the growing safety evidence for RSV immunizations,” the organizations wrote.
According to the medical groups, flu vaccination is effective among children ages 6 months through 17 years with pre-existing conditions, COVID-19 vaccination “associated with a 76% reduction in COVID-19-related emergency department visits among children ages 9 months through 4 years,” and RSV vaccination is recommended for children 8 months and younger.
President Trump’s recent executive order on childhood vaccines declared that his administration is “taking further action to reaffirm that it is the policy of the United States that the core childhood vaccine recommendations should be aligned with scientific evidence and best practices from peer, developed countries while preserving access to vaccines currently available to Americans.”
The vaccines recommended for all children include those for measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type B, pneumococcal disease, human papillomavirus, and varicella, the order says. Vaccines for certain high-risk groups include respiratory syncytial virus monoclonal antibodies, hepatitis A, hepatitis B, meningococcal B, meningococcal ACWY, and dengue.
Inoculations that are considered shared clinical decision-making include hepatitis A, hepatitis B, rotavirus, meningococcal disease, influenza, and COVID-19.
